| Schedule of Computation of Basic and Diluted Net Loss Per Share |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | | Six months ended June 30, | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | | | | Non-voting | | | | | | Non-voting | | | | | | Non-voting | | | | | | Non-voting | | Ordinary | Ordinary | Ordinary | Ordinary | | | Ordinary | | | Ordinary | | Ordinary | Ordinary | | shares | shares | shares | shares | | | shares | | | shares | | shares | shares | | | Unaudited | | Numerator: | | | | | | | | | | | | | | | | | | | | | | | | | Net income (loss) attributable to Ordinary shareholders, basic and diluted | | $ | 4,037 | | | | $ | 280 | | | | $ | (3,851) | | | | $ | (494) | | | | $ | 59,302 | | | | $ | 4,081 | | | | $ | (11,512) | | | | $ | (1,583) | | | | | | | | | | | | | | | | | | | | | | | | | | | Denominator: | | | | | | | | | | | | | | | | | | | | | | | | | Weighted-average shares used in computing net income (loss) per share attributable to Ordinary shareholders, basic | | 260,120,438 | | | 18,039,644 | | | 277,929,745 | | | 35,642,537 | | | 262,145,467 | | | 18,039,644 | | | 287,985,819 | | | 39,592,315 | | Effect of dilutive securities: | | | | | | | | | | | Add - Employee stock options and RSUs | | 13,232,825 | | | | — | | | | — | | | | — | | | | 10,320,248 | | | | — | | | | — | | | | — | | | Weighted-average shares used in computing net income (loss) per share attributable to Ordinary shareholders, diluted | | 273,353,263 | | | 18,039,644 | | | 277,929,745 | | | 35,642,537 | | | 272,465,715 | | | 18,039,644 | | | 287,985,819 | | | 39,592,315 | | | | | | | | | | | | | | | | | | | | | | | | | | Net income (loss) per share attributable to Ordinary shareholders, basic | | $ | 0.02 | | | | $ | 0.02 | | | | $ | (0.01) | | | | $ | (0.01) | | | | $ | 0.23 | | | | $ | 0.23 | | | | $ | (0.04) | | | | $ | (0.04) | | | | | | | | | | | | | | | | | | | | | | | | | | | Net income (loss) per share attributable to Ordinary shareholders, diluted | | $ | 0.01 | | | | $ | 0.01 | | | | $ | (0.01) | | | | $ | (0.01) | | | | $ | 0.22 | | | | $ | 0.22 | | | | $ | (0.04) | | | | $ | (0.04) | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The potential number of Ordinary shares that were excluded from the computation of diluted net income (loss) per share attributable to Ordinary shareholders for the periods presented because including them would have been anti-dilutive is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | | Unaudited | | Warrants | | — | | | 12,349,990 | | — | | | 12,349,990 | | RSUs | | 292,934 | | 34,827,512 | | 3,124,672 | | 32,046,117 | | Outstanding share options | | 6,820,225 | | 9,639,763 | | 6,930,135 | | 9,908,835 | | | | | | | | | | | Total | | 7,113,159 | | 56,817,265 | | 10,054,807 | | 54,304,942 |
|